DHRS9 and arteriosclerosis disorder: As regard to arteriosclerosis, research has pinpointed protein tyrosine phosphatase receptor type J (PTPRJ) and dehydrogenase/reductase 9 (DHRS9) as pivotal biomarkers with high diagnostic accuracy for the pathological process of atherosclerosis (Xu et al., 2022).